Qdenga, India's first approved dengue vaccine, received approval from the Central Drugs Standard Control Organisation (CDSCO) in July 2026. It has been cleared for people aged 4 to 60 years. The vaccine is expected to reach the private market in the first half of 2027. Dengue is a mosquito-borne viral disease that causes large outbreaks in India every year, so a licensed vaccine is an important addition to prevention efforts.